date:Aug 19, 2014
rst quarter, a contrasting performance was visible between both market segments: The performance in Biochemicals excelled in volumes and margins, while Biobased Food Ingredients, showing some improvement versus Q1, continued to disappoint. We are currently in the middle of a thorough strategic process, the outcome of which we will present in November. The strategic process is focused on future prospects for growth and value creation for Corbion and its shareholders.
H1 2014 net sales was on par